APOC3 gene variants influence both pharmacokinetics and pharmacodynamics of certain drugs, affecting their efficacy and safety. Variations in APOC3 can affect the metabolism and effectiveness of drugs like olanzapine, ritonavir, and fenofibrate in managing lipid-related disorders and cardiovascular risks, potentially requiring dosage adjustments and impacting drug performance.